Reference
Kaburagi T, et al. Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study. Anticancer Research 38: 3145-3150, No. 5, May 2018 - Japan
Rights and permissions
About this article
Cite this article
Afatinib/erlotinib/gefitinib. Reactions Weekly 1705, 15 (2018). https://doi.org/10.1007/s40278-018-47032-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-47032-5